V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210037447 | 210022068 | 1.6 | 62 | Curative (C) | null | 2014-07-18 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | Y | N | 210037370 | GEMCITABINE |
| 210037448 | 210012845 | 1.67 | 35.5 | Curative (C) | 2018-08-15 | 2018-08-15 | TRASTUZUMAB | 02 | N | 210037617 | GEMCARBO |
| 210037449 | 210038650 | null | 47.7 | Curative (C) | 2015-03-23 | 2016-01-17 | Bevacizumab + Temozolomide | N | N | 210037781 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210037450 | 210022116 | null | 47 | Curative (C) | 2017-01-23 | 2017-10-03 | ICE-R | 02 | null | 210037785 | ICE |
| 210037451 | 210027905 | 1.84 | 68 | Curative (C) | 2018-10-30 | 2018-10-30 | MELPHALAN | 02 | N | 210038157 | CARBOPLATIN + PACLITAXEL |
| 210037452 | 210027917 | 1.83 | 77.5 | Curative (C) | 2017-01-08 | 2017-01-08 | Alemtuzumab + Cyclophos TBI Allo | N | N | 210038312 | IMMUNOGLOBULIN |
| 210037453 | 210013068 | 1.65 | 58.1 | Curative (C) | 2019-02-22 | 2019-02-25 | CLL210 TRIAL | Y | N | 210038669 | UKALL2003 |
| 210037454 | 210027961 | 0 | 77.7 | Curative (C) | null | 2020-03-20 | Docetaxel + Nintedanib | N | N | 210039036 | DOCETAXEL |
| 210037455 | 210033634 | null | 66.4 | Curative (C) | 2014-08-09 | 2015-08-18 | BR14 TRIAL | N | N | 210039212 | MELPHALAN |
| 210037456 | 210013261 | null | 64 | null | 2016-08-27 | 2016-08-27 | CYCLET | 02 | null | 210039601 | FLA |
| 210037457 | 210013272 | 1.76 | 88.7 | Curative (C) | 2018-10-02 | 2019-05-14 | Cytarabine intrathecal | 02 | null | 210039685 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 210037458 | 210022337 | 1.77 | 91.2 | Palliative (P) | null | 2016-03-09 | Bexarotene | N | N | 210039746 | CLL210 TRIAL |
| 210037459 | 210013316 | null | 81.8 | Curative (C) | 2017-04-28 | 2017-05-13 | CLL210 TRIAL | N | N | 210039899 | OBINUTUZUMAB |
| 210037460 | 210013418 | 1.62 | 16.8 | Curative (C) | 2018-01-29 | 2018-01-29 | IDARUBICIN | N | N | 210040628 | UKALL2003 |
| 210037461 | 210013494 | null | 87.9 | Curative (C) | 2015-09-29 | 2015-09-29 | Lenalidomide 25mg (Cycle 1 to 25) | N | N | 210041021 | IGEV R |
| 210037462 | 210028093 | null | 69.9 | Palliative (P) | 2016-05-01 | 2016-11-17 | Docetaxel | Y | N | 210041357 | FLAG |
| 210037463 | 210022531 | 1.72 | 98.9 | Curative (C) | 2019-01-10 | 2019-02-11 | CNS LGG Irinotecan & Bevacizumab | N | N | 210042069 | FLUDARABINE |
| 210037464 | 210013674 | 1.46 | 95.6 | Palliative (P) | 2018-12-27 | 2018-12-27 | MARALL TRIAL | N | N | 210000284 | CVD |
| 210037465 | 210013787 | null | 47 | Curative (C) | null | 2018-11-30 | GemCarbo Days 1+8 | Y | null | 210028705 | ICE-R |
| 210037466 | 210013884 | null | null | Palliative (P) | 2017-09-25 | 2018-01-23 | NHL 2003 Gp B CYM 1 & 2 | N | null | 210033322 | CYTARABINE |
| 210037467 | 210013932 | 1.62 | null | Palliative (P) | 2017-06-11 | 2018-11-12 | CLL210 TRIAL | null | null | 210035201 | OBINUTUZUMAB |
| 210037468 | 210013953 | 1.82 | 70.5 | null | null | 2018-10-17 | Maintenance Therapy ALL | N | N | 210036454 | CLL210 TRIAL |
| 210037469 | 210014052 | 1.63 | 29.6 | Curative (C) | 2020-01-30 | 2020-03-07 | Ofatumumab Loading | N | N | 210041781 | CODOX M |
| 210037470 | 210028275 | null | 88 | Curative (C) | null | 2019-07-11 | Bortezomib + Panobinostat | N | N | 210034307 | RCEOP |
| 210037472 | 210038311 | 1.71 | null | Palliative (P) | 2017-04-12 | 2017-04-13 | TEMOZOLOMIDE | 02 | null | 210000612 | TEMOZOLOMIDE |
| 210037473 | 210004511 | 1.58 | 89.9 | Adjuvant (A) | 2019-09-24 | 2020-01-24 | Temozolomide 200mg/m2 | N | N | 210001305 | TEMOZOLOMIDE |
| 210037474 | 210004531 | 1.78 | 72.5 | Adjuvant (A) | 2014-12-30 | 2015-01-06 | TEMOZOLOMIDE | N | N | 210001469 | TEMOZOLOMIDE |
| 210037475 | 210017348 | 1.68 | 107.9 | Curative (C) | 2016-12-01 | 2017-02-08 | Temozolomide 200mg/m2 | N | Y | 210001686 | TEMOZOLOMIDE |
| 210037478 | 210017381 | 1.93 | 78.9 | Palliative (P) | 2013-10-14 | 2014-11-21 | Temozolomide 200mg/m2 | 02 | N | 210002085 | TEMOZOLOMIDE |
| 210037479 | 210004761 | 1.64 | 22.5 | Curative (C) | 2015-04-28 | 2015-11-24 | ALL UKALL2011 Maintenance B4 | Y | N | 210002776 | UKALL2011 |
| 210037480 | 210017477 | 0 | null | Curative (C) | 2018-03-27 | 2018-04-11 | ALL UKALL2011 IndB Std Dex (PegAsp) | N | null | 210003399 | UKALL2011 |
| 210037481 | 210017493 | 1.78 | 20.3 | Curative (C) | 2018-04-05 | 2018-10-19 | ALL UKALL2011 Maintenance A1 | N | N | 210003544 | UKALL2011 |
| 210037482 | 210035781 | 1.57 | 38.35 | Curative (C) | 2016-11-27 | 2016-11-27 | ALL UKALL2011 Ind A Std Dex (PAsp) | Y | null | 210003740 | UKALL2011 |
| 210037483 | 210035787 | null | 14.9 | Curative (C) | 2015-11-25 | 2017-01-13 | ALL UKALL2011 Maintenance A1 | Y | null | 210003897 | UKALL2011 |
| 210037484 | 210004978 | 0 | 16.8 | Curative (C) | 2017-07-07 | 2017-12-15 | ALL UKALL2011 (ProtM-A) C PegAsp | Y | N | 210004002 | UKALL2011 |
| 210037485 | 210017539 | 0 | null | Curative (C) | 2017-05-22 | 2017-05-22 | ALL UKALL2011 Cap Int Maint C PAsp | Y | null | 210004115 | UKALL2011 |
| 210037486 | 210005023 | 1.88 | 59 | Curative (C) | 2015-05-20 | 2016-10-12 | ALL UKALL2011 Maintenance A1 | Y | N | 210004223 | UKALL2011 |
| 210037487 | 210024959 | 0.71 | 60.2 | Curative (C) | 2016-10-24 | 2017-05-03 | ALL UKALL2011 Del Int C Recon PAsp | Y | N | 210004369 | UKALL2011 |
| 210037488 | 210024963 | 0 | 17.9 | null | 2018-05-16 | 2018-05-16 | ALL UKALL2011 Std BFM Cons B | Y | null | 210004402 | UKALL2011 |
| 210037489 | 210017578 | null | 47.8 | Curative (C) | 2014-07-10 | 2014-11-20 | ALL UKALL2011 Del Int A Pt1 (PAsp) | Y | N | 210004493 | UKALL2011 |
| 210037490 | 210017581 | null | 32.6 | Curative (C) | 2016-06-06 | 2016-09-09 | ALL UKALL2011 Std Int Maint A | Y | N | 210004496 | UKALL2011 |
| 210037491 | 210017599 | 0.95 | 44.9 | Curative (C) | 2016-09-25 | 2017-05-22 | ALL UKALL2011 Maintenance A1 | Y | N | 210004715 | UKALL2011 |
| 210037492 | 210032632 | 1.13 | 16.1 | Curative (C) | 2017-01-01 | 2017-01-22 | ALL UKALL2011 Aug BFM Cons C PegAsp | Y | null | 210004847 | UKALL2011 |
| 210037493 | 210017630 | 1.09 | null | Curative (C) | 2018-06-04 | 2018-07-20 | ALL UKALL2011 Del Int A Pt1 (PAsp) | Y | null | 210005122 | UKALL2011 |
| 210037494 | 210005187 | 1.26 | 18 | Curative (C) | 2013-11-26 | 2014-05-07 | ALL UKALL2011 Del Int A Pt1 (PAsp) | Y | N | 210005131 | UKALL2011 |
| 210037495 | 210005205 | null | 29.4 | Curative (C) | 2014-05-11 | 2014-09-13 | ALL UKALL2011 (ProtM-A) C PegAsp | Y | N | 210005198 | UKALL2011 |
| 210037496 | 210005230 | null | null | Curative (C) | 2015-12-16 | 2016-05-27 | ALL UKALL2011 Std Int Maint A | Y | N | 210005288 | UKALL2011 |
| 210037497 | 210034549 | 1.79 | 21.5 | Curative (C) | 2015-01-29 | 2015-02-14 | ALL UKALL2011 Maintenance A1 | Y | Y | 210005293 | UKALL2011 |
| 210037498 | 210017661 | 1 | 40.3 | Curative (C) | 2016-11-24 | 2018-07-23 | ALL UKALL2011 Del Int C Recon PAsp | Y | N | 210005410 | UKALL2011 |
| 210037500 | 210005276 | 1.06 | 15 | Curative (C) | null | 2018-03-21 | ALL UKALL2011 IndB Std Dex (PegAsp) | Y | Y | 210005470 | UKALL2011 |